Mitoxantrone FDA Link Generic

An anthracenedione-derived antineoplastic agent.

Also Known As:

Novantrone; CL-232325; DHAQ; Mitoxantrone Acetate; Mitoxantrone Hydrochloride; Mitroxone; NSC-279836; NSC-287836; NSC-299195; NSC-301739; NSC-301739D; Novantron; Onkotrone; Pralifan; Ralenova; Acetate, Mitoxantrone; CL 232325; CL232325; Hydrochloride, Mitoxantrone; NSC 279836; NSC 287836; NSC 299195; NSC 301739; NSC 301739D; NSC279836; NSC287836; NSC299195; NSC301739; NSC301739D; Mitozantrone; 9,10-Anthracenedione, 1,4- dihydroxy- 5,8- bis((2- ((2- hydroxyethyl)amino)ethyl)amino)-

Pharmalogical Action Categories:

Analgesics
Antineoplastic Agents
Topoisomerase II Inhibitors

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Anthracenes: 12
        Anthrones: 12
        Anthraquinones: 788
        Mitoxantrone: 2907
- Quinones: 434
  - Anthraquinones: 788
    - Mitoxantrone: 2907
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Anthracenes: 12
    - Anthrones: 12
      - Anthraquinones: 788
        Mitoxantrone: 2907

8,11- dihydroxy- 4- (2- hydroxyethyl)- 6- ((2- ((2- hydroxyethyl)amino)ethyl)amino)- 1,2,3,4,7,12- hexahydronaphtho(2,3- f)quinoxaline- 7,12- dione

Bio-Agent Context: Research Results